Drug Type Monoclonal antibody |
Synonyms ARG-098, DE 098, DE-098 |
Target |
Action inhibitors |
Mechanism FasR inhibitors(Apoptosis-mediating surface antigen FAS inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rheumatoid Arthritis | Phase 2 | Japan | - | - |
| Rheumatoid Arthritis | Phase 2 | Europe | - | |
| Rheumatoid Arthritis | Phase 2 | - | - | |
| Rheumatoid Arthritis | Phase 2 | - | - | |
| Rheumatoid Arthritis | Phase 2 | - | - |
Phase 1/2 | 43 | fphmotchsv(crvyumoqqr) = qtzqcchrtp mcvndzkehy (vgevctbfpb ) | - | 06 Jun 2012 | |||
fphmotchsv(crvyumoqqr) = rvvtwpgqoi mcvndzkehy (vgevctbfpb ) |






